Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V
Receptor tyrosine kinase mutations are frequent and associated with poor prognosis in acute myeloid leukemia (AML). Here the authors show that the antipsychotic drug chlorpromazine reduces AML cells viability by perturbing the intracellular localization of FLT3-ITD and KIT-D816V.
Guardado en:
Autores principales: | Shinya Rai, Hirokazu Tanaka, Mai Suzuki, J. Luis Espinoza, Takahiro Kumode, Akira Tanimura, Takafumi Yokota, Kenji Oritani, Toshio Watanabe, Yuzuru Kanakura, Itaru Matsumura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d959de3d6524e5897ad361f125459c1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FLT3-ITD POSITIVITY IN AML; CASE SERIES
por: Kemal FİDAN
Publicado: (2021) -
HSP70 and FLT3-ITD: Targeting chaperone system to overcome drug resistance
por: Jing Yang, et al.
Publicado: (2021) -
Modulation of FLT3-ITD Localization and Targeting of Distinct Downstream Signaling Pathways as Potential Strategies to Overcome FLT3-Inhibitor Resistance
por: Maximilian Fleischmann, et al.
Publicado: (2021) -
Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells
por: Jonathan Metts, et al.
Publicado: (2017) -
Acta Nº816
por: Banco Central de Chile
Publicado: (2019)